- Home
- J vs SNN Comparison
J vs SNN Comparison
Compare J & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | J | SNN |
|---|---|---|
| Founded | 1947 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5B | 14.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | J | SNN |
|---|---|---|
| Price | $139.47 | $36.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $156.60 | $35.75 |
| AVG Volume (30 Days) | ★ 1.1M | 804.7K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 1.04% | ★ 1.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $14,984,646,000.00 | N/A |
| Revenue This Year | $13.41 | $7.68 |
| Revenue Next Year | N/A | $5.47 |
| P/E Ratio | $124.44 | ★ $64.97 |
| Revenue Growth | ★ 49.51 | N/A |
| 52 Week Low | $106.23 | $23.91 |
| 52 Week High | $168.44 | $38.79 |
Technical Indicators
Market Signals| Indicator | J | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 51.35 | 60.27 |
| Support Level | $131.96 | $36.53 |
| Resistance Level | $141.60 | $37.26 |
| Average True Range (ATR) | 6.16 | 0.55 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 49.32 | 80.40 |
Price Performance
Historical ComparisonAbout J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $12 billion in revenue in fiscal 2025.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.